Oaktree Capital Management closed its Life Sciences Lending Fund and its related vehicles (“the Fund”), with total capital commitments in excess of $2.3 billion. The Fund, which is Oaktree’s first dedicated life sciences fund, was oversubscribed and builds on our track record of successfully investing in this specialized field for over a decade.